A groundbreaking study from the Garvan Institute of Medical Research has unveiled a critical mechanism behind treatment resistance in estrogen receptor-positive (ER+) breast cancer, revealing new avenues for precision therapy. This investigation illuminates how the suppression of
English (US) ·